397 related articles for article (PubMed ID: 32629016)
21. How to compare the efficacy of biologic agents in asthma.
Viswanathan RK; Busse WW
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169
[TBL] [Abstract][Full Text] [Related]
22. Asthma biologics: Comparing trial designs, patient cohorts and study results.
Doroudchi A; Pathria M; Modena BD
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):44-56. PubMed ID: 31655122
[TBL] [Abstract][Full Text] [Related]
23. Thai pediatricians' current practice toward childhood asthma.
Kamalaporn H; Chawalitdamrong P; Preutthipan A
J Asthma; 2018 Apr; 55(4):402-415. PubMed ID: 28696803
[TBL] [Abstract][Full Text] [Related]
24. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.
Pepper AN; Hanania NA; Humbert M; Casale TB
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1081-1088. PubMed ID: 33685606
[TBL] [Abstract][Full Text] [Related]
25. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
Huffaker MF; Phipatanakul W
Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Real-World Escalation to Biologics in US Patients With Asthma.
Bender B; Oppenheimer J; George M; Brown R; Patel A; Hill T; Boe A; Mayen Herrera E; Dotiwala Z; Casciano J; Bernstein JA
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2941-2948. PubMed ID: 35931363
[TBL] [Abstract][Full Text] [Related]
27. Biologics in the treatment of asthma in children and adolescents.
Bacharier LB; Jackson DJ
J Allergy Clin Immunol; 2023 Mar; 151(3):581-589. PubMed ID: 36702649
[TBL] [Abstract][Full Text] [Related]
28. [THE OVERLAPPING ELIGIBILITY FOR BIOLOGICS IN PATIENTS WITH SEVERE ASTHMA AND PHENOTYPES].
Ito A; Miyoshi S; Toyota H; Suzuki Y; Uehara Y; Hattori S; Takeshita Y; Sakasegawa H; Kuramochi M; Kobayashi K; Sugimoto N; Nagase H
Arerugi; 2022; 71(3):210-220. PubMed ID: 35569943
[TBL] [Abstract][Full Text] [Related]
29. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
Santus P; Saad M; Damiani G; Patella V; Radovanovic D
Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
[TBL] [Abstract][Full Text] [Related]
30. New perspectives of childhood asthma treatment with biologics.
Just J; Deschildre A; Lejeune S; Amat F
Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life Evaluation.
Eger K; Kroes JA; Ten Brinke A; Bel EH
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1194-1200. PubMed ID: 33069885
[TBL] [Abstract][Full Text] [Related]
32. Biologics in asthma--the next step toward personalized treatment.
Darveaux J; Busse WW
J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
[TBL] [Abstract][Full Text] [Related]
33. Asthma biologics: Real-world effectiveness, impact of switching biologics, and predictors of response.
Abbas F; Georas S; Cai X; Khurana S
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):655-660.e1. PubMed ID: 34481992
[TBL] [Abstract][Full Text] [Related]
34. Biological treatments for severe asthma.
Assaf SM; Hanania NA
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):379-386. PubMed ID: 31169594
[TBL] [Abstract][Full Text] [Related]
35. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma.
Yılmaz İ; Paçacı Çetin G; Arslan B; Şeker S; Bozkurt Yılmaz HE; Aktaş Yapıcı E; Köylüce S; Açar E
Tuberk Toraks; 2023 Mar; 71(1):75-93. PubMed ID: 36912412
[TBL] [Abstract][Full Text] [Related]
36. Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine.
Mustafa SS; Patrawala S; Khurana S
Curr Opin Pulm Med; 2022 May; 28(3):266-273. PubMed ID: 35131991
[TBL] [Abstract][Full Text] [Related]
37. Physicians' preference for controller medication in mild persistent asthma.
Bakirtas A; Kutlu A; Baccioglu A; Erkekol FO; Bavbek S; Kalayci O;
Respir Med; 2017 Oct; 131():236-240. PubMed ID: 28947037
[TBL] [Abstract][Full Text] [Related]
38. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
Rogers L; Jesenak M; Bjermer L; Hanania NA; Seys SF; Diamant Z
Respir Med; 2023 Nov; 218():107414. PubMed ID: 37776915
[TBL] [Abstract][Full Text] [Related]
39. Biologics in pediatric lung disease.
McGhee SA
Curr Opin Pediatr; 2018 Jun; 30(3):366-371. PubMed ID: 29538045
[TBL] [Abstract][Full Text] [Related]
40. Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals.
Akenroye AT; Heyward J; Keet C; Alexander GC
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):3969-3976. PubMed ID: 33556592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
